Semnur Pharmaceuticals reported total assets of $1.94M and total liabilities of $31.62M for the quarter ended Jun 2026, up 245.4% year over year. This balance sheet covers 18 quarters of results from Mar 2022 through Jun 2026, standardized by Business Quant from the company’s SEC filings.
| Balance SheetBalance Sheet | Mar2022 | Jun2022 | Sep2022 | Dec2022 | Mar2023 | Jun2023 | Sep2023 | Dec2023 | Mar2024 | Jun2024 | Sep2024 | Dec2024 | Mar2025 | Jun2025 | Sep2025 | Dec2025 | Mar2026 | Jun2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets | ||||||||||||||||||
| Current Assets | ||||||||||||||||||
| Cash & EquivalentsCash & Equiv. | 0.02M | 1.11M | 0.99M | 0.82M | 0.01M | 0.01M | 0.20M | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M | 126.00 | 0.10M | 0.02M | 0.10M | 0.04M | |
| Cash & Current Investments | 0.02M | 1.11M | 0.99M | 0.82M | 0.01M | 0.01M | 0.20M | 0.00M | 0.00M | 0.01M | 0.01M | 0.00M | 126.00 | 0.10M | 0.02M | 0.10M | 0.04M | |
| Prepaid Assets | 0.15M | 0.13M | 0.09M | 0.09M | 0.05M | 0.02M | 0.00M | 0.06M | 0.04M | 0.02M | 0.00M | 0.01M | 0.58M | 1.12M | 1.10M | |||
| Current Assets | 0.02M | 1.26M | 1.12M | 0.91M | 0.67M | 0.05M | 0.04M | 0.21M | 0.07M | 0.04M | 0.04M | 6.00M | 0.00M | 0.01M | 0.09M | 0.60M | 1.22M | 1.19M |
| Non-Current Assets | ||||||||||||||||||
| Property, Plant & Equipment (Net)PP&E (Net) | 0.69M | 0.69M | 0.75M | 0.75M | 0.75M | |||||||||||||
| Long-Term Investments | 84.26M | 84.65M | 85.37M | 86.28M | 88.14M | 90.11M | 0.15M | 51.28M | 52.07M | 8.89M | 9.02M | 9.15M | 0.55M | |||||
| Intangibles | 5.00M | |||||||||||||||||
| Goodwill & Intangibles | 5.00M | |||||||||||||||||
| Other Non-Current Assets | 0.43M | 0.00M | ||||||||||||||||
| Non-Current Assets | 0.43M | 84.27M | 84.65M | 85.37M | 86.28M | 88.14M | 90.11M | 50.48M | 51.28M | 52.07M | 8.89M | 0.69M | 9.15M | 0.55M | 0.69M | 0.75M | 0.75M | 0.75M |
| Assets | 0.44M | 85.53M | 85.76M | 86.28M | 86.96M | 88.19M | 90.15M | 50.69M | 51.35M | 52.12M | 8.92M | 6.68M | 9.15M | 0.56M | 0.77M | 1.35M | 1.97M | 1.94M |
| Liabilities | ||||||||||||||||||
| Current Liabilities | ||||||||||||||||||
| Accounts Payables | 0.13M | 0.08M | 0.09M | 1.29M | 2.98M | 3.34M | 3.74M | 3.75M | 3.80M | 3.83M | 3.86M | 4.77M | 5.09M | 4.29M | 5.91M | 6.42M | 6.92M | |
| Notes Payables | 0.41M | 0.83M | 0.98M | 1.13M | 1.28M | 1.31M | 1.40M | 1.40M | 4.50M | 3.52M | 2.80M | 2.11M | ||||||
| Payables | 0.13M | 0.08M | 0.09M | 1.29M | 2.98M | 3.75M | 4.57M | 4.72M | 4.93M | 5.11M | 5.16M | 6.17M | 6.49M | 8.79M | 9.43M | 9.22M | 9.03M | |
| Accumulated Expenses | 0.01M | 0.02M | 0.03M | 0.04M | 0.06M | 0.04M | 0.11M | 0.11M | 1.27M | 0.74M | 1.19M | 1.65M | ||||||
| Other Accumulated Expenses | 0.01M | 0.02M | 0.03M | 0.04M | 0.05M | 0.03M | 0.07M | 0.08M | 0.02M | 0.00M | 0.02M | 0.18M | ||||||
| Total Current Liabilities | 0.43M | 0.16M | 0.09M | 1.29M | 2.98M | 3.75M | 5.08M | 5.60M | 6.00M | 6.32M | 6.59M | 0.04M | 7.85M | 8.27M | 10.03M | 10.17M | 10.38M | 10.67M |
| Non-Current Liabilities | ||||||||||||||||||
| Non-Current Debt | 0.00M | 0.49M | 0.29M | 0.47M | ||||||||||||||
| Preferred Stock Liabilities | 84.15M | 84.65M | 85.37M | 86.28M | 88.14M | 90.11M | 50.48M | 51.28M | 52.07M | 8.89M | 9.02M | 9.15M | 0.55M | |||||
| Total Liabilities | 0.43M | 87.20M | 87.62M | 89.55M | 92.15M | 94.78M | 98.08M | 88.78M | 90.95M | 92.83M | 50.93M | 49.47M | 52.60M | 45.01M | 15.37M | 22.10M | 27.30M | 31.62M |
| Shareholder's Equity | ||||||||||||||||||
| Total Debt | 0.42M | 1.32M | 0.98M | 1.13M | 1.56M | 1.77M | 1.40M | 1.40M | 4.50M | 3.52M | 2.80M | 2.11M | ||||||
| Common Equity | 0.01M | -1.67M | -1.86M | -3.27M | -5.19M | -6.59M | -7.93M | -38.09M | -39.60M | -40.71M | -42.01M | -42.78M | -43.45M | -44.45M | -14.59M | -20.75M | -25.33M | -29.67M |
| Liabilities and Shareholders Equity | 0.44M | 85.53M | 85.76M | 86.28M | 86.96M | 88.19M | 90.15M | 50.69M | 51.35M | 52.12M | 8.92M | 6.68M | 9.15M | 0.56M | 0.77M | 1.35M | 1.97M | 1.94M |
| Retained Earnings | -0.01M | -1.67M | -1.86M | -3.27M | -5.19M | -6.59M | -7.93M | -8.28M | -8.82M | -9.16M | -9.45M | -115.38M | -10.74M | -11.14M | -269.64M | -275.80M | -280.40M | -284.72M |
| Preferred Shares | 0.00M | 0.00M | 0.00M | 0.00M |
Pull Semnur Pharmaceuticals's standardized financial statements into your own models, spreadsheets and apps with the Business Quant Financial Statements API. The request below follows the statement, frequency and period selected above. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/statements?ticker=SMNR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/statements"
params = {"ticker": "SMNR", "statement": "BS", "frequency": "Quarter", "period": "all", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/statements?ticker=SMNR&statement=BS&frequency=Quarter&period=all&api_key=YOUR_API_KEY");
const data = await res.json();